Apotex Pharmachem India Private Limited, a active private limited company, was established on 16 June 2003 in Bangalore, Karnataka, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24231KA2003PTC032104. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹76.31 Cr.
Formerly known as Brantford Chemicals Private Limited. It upholds a active non-compliant status. Employing 209 professional, Its leadership includes Brian George Mcclelland (Director), Yoganjaneya Reddy Panem (Director), Uta Kellermann Renton (Director). Past directors included Brian George Mcclelland, Padiyath Mohammed Akbarali, Rajesh Kumar Goel. It holds no open charges and ₹137.20 Cr settled loans. Its latest AGM occurred on 24 September 2024, with the balance sheet filed on 31 March 2024. It is based at Site No. 1 A,Bommasandra Industrial Area, 1V Th Phase, Jigani Link Road,, Bangalore, Karnataka, 562158.
U24231KA2003PTC032104
032104
16 June 2003
₹100.00 Cr
₹76.31 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Apotex Pharmachem India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Brian George Mcclelland | Director | 15 Sep 2023 | Current |
| Yoganjaneya Reddy Panem | Director | 09 Jun 2015 | Current |
| Uta Kellermann Renton | Director | 23 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 21 Sep 2023 | Past |
| Pramod Abcsdd | Managing Director | 08 May 2014 | Past |
| Pramod Abcsdd | Company Secretary | 27 Apr 2018 | Past |
| Pramod Abcsdd | Director | 16 Jan 2015 | Past |
| Pramod Abcsdd | Director | 26 Oct 2009 | Past |
| Pramod Abcsdd | Director | 08 May 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Apotex Pharmachem India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.58% decrease. The company also saw a substantial improvement in profitability, with a 26.36% increase in profit. The company's net worth moved up by a moderate rise of 3.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Apotex Pharmachem India had a promoter holding of 99.93% and a public holding of 0.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,372,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2016 | The Hongkong And Shanghai Banking Corporation Limited | ₹6.00 M | Satisfied |
| 24 Apr 2014 | The Hongkong And Shanghai Banking Corporation Limited | ₹19.80 Cr | Satisfied |
| 27 Sep 2013 | The Hongkong And Shanghai Banking Corporation Ltd | ₹19.80 Cr | Satisfied |
| 12 Jan 2010 | State Bank Of India | ₹32.00 Cr | Satisfied |
| 31 Mar 2006 | Apotex Pharmaceutical Holdings Inc | ₹65.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Apotex Pharmachem India has a workforce of 209 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Apotex Pharmachem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apotex Pharmachem India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Uta Kellermann Renton was appointed as a Director was appointed as a Director on 23 Sep 2025 & has been associated with this company since 2 months 6 days . was recorded as a recent event.
Indrajyoti Bose was appointed as a Cfo was appointed as a Cfo on 28 Apr 2025 & has been associated with this company since 7 months 1 day . was recorded as a recent event.
Apotex Pharmachem India Private Limited last Annual general meeting of members was held on 24 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Apotex Pharmachem India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Brian George Mcclelland was appointed as a Director was appointed as a Director on 15 Sep 2023 & has been associated with this company since 2 years 2 months . was recorded as a recent event.
Progress on A charge registered on 31 Mar 2006 via Charge ID 10004977 with Apotex Pharmaceutical Holdings Inc was fully satisfied on 14 Dec 2021. was documented.
The CIN of Apotex Pharmachem India Private Limited is U24231KA2003PTC032104.
Apotex Pharmachem India Private Limited is headquartered at Site No. 1 A,Bommasandra Industrial Area, 1V Th Phase, Jigani Link Road,, Bangalore, Karnataka, 562158.
Apotex Pharmachem India Private Limited was incorporated on 16 June 2003.
The current directors of Apotex Pharmachem India Private Limited are
The primary industry of Apotex Pharmachem India Private Limited is Manufacturing.
Apotex Pharmachem India Private Limited is unlisted.
The authorized capital of Apotex Pharmachem India Private Limited is ₹100.00 Cr, and the paid-up capital is ₹76.31 Cr.
The compliance status of Apotex Pharmachem India Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX